JP2023518543A5 - - Google Patents
Info
- Publication number
- JP2023518543A5 JP2023518543A5 JP2022556248A JP2022556248A JP2023518543A5 JP 2023518543 A5 JP2023518543 A5 JP 2023518543A5 JP 2022556248 A JP2022556248 A JP 2022556248A JP 2022556248 A JP2022556248 A JP 2022556248A JP 2023518543 A5 JP2023518543 A5 JP 2023518543A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- optionally substituted
- halogen
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062992616P | 2020-03-20 | 2020-03-20 | |
| US62/992,616 | 2020-03-20 | ||
| PCT/US2021/023228 WO2021188944A1 (en) | 2020-03-20 | 2021-03-19 | Phd inhibitor compounds, compositions, and their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518543A JP2023518543A (ja) | 2023-05-02 |
| JP2023518543A5 true JP2023518543A5 (https=) | 2024-05-29 |
Family
ID=75478265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556248A Pending JP2023518543A (ja) | 2020-03-20 | 2021-03-19 | Ｐｈｄ阻害剤化合物、組成物、及びそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230212138A1 (https=) |
| EP (1) | EP4121424A1 (https=) |
| JP (1) | JP2023518543A (https=) |
| CN (2) | CN120004851A (https=) |
| AR (1) | AR121626A1 (https=) |
| WO (1) | WO2021188944A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11713298B2 (en) | 2018-05-09 | 2023-08-01 | Akebia Therapeutics, Inc. | Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid |
| WO2021117767A1 (ja) | 2019-12-10 | 2021-06-17 | 田辺三菱製薬株式会社 | 含窒素ヘテロアリールカルボキサミド酢酸誘導体の製造方法 |
| EP4447963A1 (en) * | 2021-12-17 | 2024-10-23 | Akebia Therapeutics Inc. | Selective phd1 inhibitor compounds, compositions, and methods of use |
| CN118745146B (zh) * | 2024-06-24 | 2025-09-23 | 上海坦泰生物科技有限公司 | 一种5-氟-2-肼基吡啶二盐酸盐的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663327A (en) * | 1984-05-23 | 1987-05-05 | Bayer Aktiengesellschaft | 1-heteroaryl-4-aryl-pyrazolin-5-ones |
| DE3443308A1 (de) * | 1984-11-28 | 1986-05-28 | Bayer Ag, 5090 Leverkusen | 1-heteroaryl-4-aryl-pyrazolin-5-one zur verwendung als arzneimittel |
| DE102005019712A1 (de) * | 2005-04-28 | 2006-11-09 | Bayer Healthcare Ag | Dipyridyl-dihydropyrazolone und ihre Verwendung |
| DE102006050516A1 (de) * | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte Dihydropyrazolone und ihre Verwendung |
| DE102006050512A1 (de) * | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte heterocyclische Verbindungen und ihre Verwendung |
| DE102006050515A1 (de) * | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung |
| DE102007044032A1 (de) * | 2007-09-14 | 2009-03-19 | Bayer Healthcare Ag | Substituierte heterocyclische Verbindungen und ihre Verwendung |
| WO2010005851A1 (en) * | 2008-07-08 | 2010-01-14 | Xenon Pharmaceuticals Inc. | Combination therapy for treating iron disorders |
| CA2894399A1 (en) * | 2012-12-06 | 2014-06-12 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
| EA031647B1 (ru) * | 2013-03-29 | 2019-02-28 | Такеда Фармасьютикал Компани Лимитед | 6-(5-гидрокси-1h-пиразол-1-ил)никотинамидные ингибиторы phd |
-
2021
- 2021-03-19 JP JP2022556248A patent/JP2023518543A/ja active Pending
- 2021-03-19 AR ARP210100701A patent/AR121626A1/es unknown
- 2021-03-19 EP EP21718378.9A patent/EP4121424A1/en active Pending
- 2021-03-19 WO PCT/US2021/023228 patent/WO2021188944A1/en not_active Ceased
- 2021-03-19 US US17/906,653 patent/US20230212138A1/en active Pending
- 2021-03-19 CN CN202510158546.8A patent/CN120004851A/zh active Pending
- 2021-03-19 CN CN202180034141.3A patent/CN115605467B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518543A5 (https=) | ||
| JP2023171659A5 (https=) | ||
| JP2023518286A5 (https=) | ||
| JP2005514420A5 (https=) | ||
| JP2023518262A5 (https=) | ||
| JP6722200B2 (ja) | 複素環化合物の合成 | |
| CA2820109C (en) | Pyridine amide derivatives as ep4 receptor antagonists | |
| JP2021169499A5 (https=) | ||
| AU2019414550A1 (en) | Fak inhibitor and drug combination thereof | |
| JP2021514001A5 (https=) | ||
| JP2007524696A5 (https=) | ||
| JP2024530952A5 (https=) | ||
| JP2024519140A5 (https=) | ||
| JP2023518953A5 (https=) | ||
| JP2008510762A5 (https=) | ||
| JP2002516314A5 (https=) | ||
| JP2010538076A5 (https=) | ||
| JP2024529527A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| JP2005511545A5 (https=) | ||
| JP2019500315A5 (https=) | ||
| JP2005536519A5 (https=) | ||
| JP2024545787A5 (https=) | ||
| JP2023531495A5 (https=) | ||
| JP2020512400A5 (https=) |